Quest Diagnostics (DGX) Total Current Liabilities (2009 - 2026)
Quest Diagnostics (DGX) posted Total Current Liabilities of $1.8 billion for Q2 2026, down 17.87% sequentially from $2.2 billion in Q1 2026, and down 11.66% YoY from $2.0 billion in Q2 2025.
Quest Diagnostics (DGX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Total Current Liabilities for 18 years, with the latest figure at $1.8 billion in Q2 2026.
- Quarterly Total Current Liabilities fell 11.66% year-over-year to $1.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (down 11.66% YoY) and the FY2025 annual result came in at $2.3 billion, up 5.03% from the prior year.
- Total Current Liabilities fell to $1.8 billion in Q2 2026 per DGX's latest filing, from $2.2 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.3 billion in Q1 2024 and troughed at $1.4 billion in Q1 2023.
- A 5-year average of $1.9 billion and a median of $1.8 billion in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 69.59% in 2024, then slumped 37.29% in 2025.
- Over 5 years, Total Current Liabilities stood at $1.6 billion in 2022, then rose by 17.02% to $1.8 billion in 2023, then advanced by 19.5% to $2.2 billion in 2024, then gained by 5.03% to $2.3 billion in 2025, then declined by 21.51% to $1.8 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.8 billion, $2.2 billion, and $2.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 553.20 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.27 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.82 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.29 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.58 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 1.20 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.12 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 1.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Bn |
| Mar 31, 2026 | 2.18 Bn |
| Dec 31, 2025 | 2.28 Bn |
| Sep 30, 2025 | 2.13 Bn |
| Jun 30, 2025 | 2.02 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 2.17 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 2.30 Bn |
| Dec 31, 2023 | 1.82 Bn |
| Sep 30, 2023 | 1.62 Bn |
| Jun 30, 2023 | 1.88 Bn |
| Mar 31, 2023 | 1.36 Bn |
| Dec 31, 2022 | 1.55 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.58 Bn |
| Mar 31, 2022 | 1.70 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Sep 30, 2021 | 1.76 Bn |